SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-144129
Filing Date
2021-11-29
Accepted
2021-11-29 09:01:08
Documents
28
Period of Report
2021-11-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2134055d1_8k.htm   iXBRL 8-K 26020
2 EXHIBIT 99.1 tm2134055d1_ex99-1.htm EX-99.1 57124
3 EXHIBIT 99.2 tm2134055d1_ex99-2.htm EX-99.2 21614
7 GRAPHIC image_004.jpg GRAPHIC 10917
8 GRAPHIC image_003.jpg GRAPHIC 33486
9 GRAPHIC image_005.jpg GRAPHIC 10917
10 GRAPHIC image_006.jpg GRAPHIC 16473
11 GRAPHIC image_007.jpg GRAPHIC 54134
12 GRAPHIC image_008.jpg GRAPHIC 7188
13 GRAPHIC image_009.jpg GRAPHIC 20141
14 GRAPHIC image_010.jpg GRAPHIC 18268
15 GRAPHIC image_011.jpg GRAPHIC 55720
16 GRAPHIC image_012.jpg GRAPHIC 163991
17 GRAPHIC image_013.jpg GRAPHIC 26118
18 GRAPHIC image_014.jpg GRAPHIC 18103
19 GRAPHIC image_001.jpg GRAPHIC 4288
20 GRAPHIC image_002.jpg GRAPHIC 33486
  Complete submission text file 0001104659-21-144129.txt   948676

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA srne-20211129.xsd EX-101.SCH 3061
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20211129_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20211129_pre.xml EX-101.PRE 22383
21 EXTRACTED XBRL INSTANCE DOCUMENT tm2134055d1_8k_htm.xml XML 3484
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 211453056
SIC: 2836 Biological Products, (No Diagnostic Substances)